Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
Learn more about niacin and find out if it can raise HDL ("good") cholesterol levels
Alaiti 2017)
[PMID: 39969044] PubMed record related to this compound for laboratory literature review
US$ 21.51
US$ 25.44
US$ 26.46
